Fresh Equities
AVITA MEDICAL LTD

AVITA MEDICAL LTD

ASX:AVH

Last Placement
Bidding Closed
Offer Price
Not Available
Discount to Close
Not Available
Raised
$40M
Last Close
$0.0820
Market Cap at Close
Not Available
Relisted
Dec 3, 2018

Company Information

Avita Medical Ltd (AVH) is a medical technology company that develops and distributes regenerative and tissue-engineered products for the treatment of wounds, scars and skin defects. The company's products includes regenerative medicine products (ReCell Autologous Spray-On-Skin), ReGenercell and Renovacell. Former Names Ecat Development Capital Limited (ECL), 11/11/2002; Greenchip Resources Limited (GRC), 31/08/1999. Clinical Cell Culture Limited (CCE), 25/06/2008.

Type

Listed Company

GICS Sub-Industry

Biotechnology

Head Office

Cambridge Rd, Melbourn, Royston SG8 6EE, UK

Biotechnology
Health Care

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.



Fresh Equities

Copyright © 2018 Fresh Equities. All rights reserved.

ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Archive
Support
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Fresh Equities Pty Ltd, its representatives or any other third party regardless of whether such security, product or service is referenced on this website.